Flagship Ventures Fund V, L.P. Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Flagship Ventures Fund V, L.P. is > 10% Shareholder of Denali Therapeutics Inc.. Currently has a direct ownership of 8.92 Million shares of DNLI, which is worth approximately $219 Million. The most recent transaction as insider was on Dec 12, 2017, when has been sold 8,606,249 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.92M
0% 3M change
0% 12M change
Total Value Held $219 Million

Flagship Ventures Fund V, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2017
BUY
Conversion of derivative security
-
8,606,249 Added 49.11%
8,918,749 Common Stock
FVF

Flagship Ventures Fund V, L.P.

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI